Epithelial membrane protein 2: a novel biomarker for circulating tumor cell recovery in breast cancer

ConclusionsEMP2 is superior to EpCAM for capturing both MCF7 and MDA-MB-231 cells. Additionally, EMP2 is a novel biomarker and capable of capturing breast cancer cells in patient blood samples.
Source: Clinical and Translational Oncology - Category: Cancer & Oncology Source Type: research